Zurück zum Zitat Dickstein K, Vardas PE, Auricchio A, Daubert JC, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ, Committee for Practice Guidelines of the European Society of Cardiology, ESC Committee for Practice Guidelines (CPG) (2010) Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 31(21):2677–2687CrossRefPubMed Dickstein K, Vardas PE, Auricchio A, Daubert JC, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ, Committee for Practice Guidelines of the European Society of Cardiology, ESC Committee for Practice Guidelines (CPG) (2010) Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 31(21):2677–2687CrossRefPubMed

Zurück zum Zitat Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH (2004) Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350(21):2151–2158CrossRefPubMed Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH (2004) Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350(21):2151–2158CrossRefPubMed

Zurück zum Zitat Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ, MADIT II Investigators (2008) Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51(14):1357–1365CrossRefPubMed Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ, MADIT II Investigators (2008) Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51(14):1357–1365CrossRefPubMed

Zurück zum Zitat Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359(10):1009–1017PubMedCentralCrossRefPubMed Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359(10):1009–1017PubMedCentralCrossRefPubMed

Zurück zum Zitat Mitka M (2009) New study supports lifesaving benefits of implantable defibrillation devices. JAMA 302(2):134–135CrossRefPubMed Mitka M (2009) New study supports lifesaving benefits of implantable defibrillation devices. JAMA 302(2):134–135CrossRefPubMed

Zurück zum Zitat Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL (2010) Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 7(3):353–360CrossRefPubMed Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL (2010) Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 7(3):353–360CrossRefPubMed

Zurück zum Zitat Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ, PainFREE Rx II Investigators. for the PainFREE Rx II Investigators (2004) Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation 110(17):2591–2596CrossRefPubMed Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ, PainFREE Rx II Investigators. for the PainFREE Rx II Investigators (2004) Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation 110(17):2591–2596CrossRefPubMed

Zurück zum Zitat Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM, EMPIRIC Trial Investigators (2006) A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 48(2):330–339CrossRefPubMed Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM, EMPIRIC Trial Investigators (2006) A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 48(2):330–339CrossRefPubMed

Zurück zum Zitat Schwab JO, Bollinger C, Veltmann C, Wiegand U, Axthelm C, Hiller S, Bodden C, Stoeppler C (2011) First results of the ATPonFastVT-study. Heart Rhythm Supplement S2 Schwab JO, Bollinger C, Veltmann C, Wiegand U, Axthelm C, Hiller S, Bodden C, Stoeppler C (2011) First results of the ATPonFastVT-study. Heart Rhythm Supplement S2

Zurück zum Zitat Gasparini M, Anselme F, Clementy J, Santini M, Martínez-Ferrer J, De Santo T, Santi E, Schwab JO, ADVANCE CRT-D Investigators (2010) BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial. Am Heart 159(6):1116–1123CrossRef Gasparini M, Anselme F, Clementy J, Santini M, Martínez-Ferrer J, De Santo T, Santi E, Schwab JO, ADVANCE CRT-D Investigators (2010) BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial. Am Heart 159(6):1116–1123CrossRef

Zurück zum Zitat Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators (2008) Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 52(7):541–545CrossRefPubMed Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators (2008) Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 52(7):541–545CrossRefPubMed

Zurück zum Zitat Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G (2009) A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT (Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD) study. Eur Heart J 30(22):2758–2767PubMedCentralCrossRefPubMed Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G (2009) A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT (Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD) study. Eur Heart J 30(22):2758–2767PubMedCentralCrossRefPubMed

Zurück zum Zitat Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB, Hersi A, Gulaj M, Wijfels MC, Santi E, Manotta L, Arenal A (2013) Effect of long-detection interval vs standard-detection interval for implantable cardioverter defibrillators on antitachycardia pacing and shock delivery. JAMA 309(18):1903–1911CrossRefPubMed Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB, Hersi A, Gulaj M, Wijfels MC, Santi E, Manotta L, Arenal A (2013) Effect of long-detection interval vs standard-detection interval for implantable cardioverter defibrillators on antitachycardia pacing and shock delivery. JAMA 309(18):1903–1911CrossRefPubMed

Zurück zum Zitat Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W, MADIT-RIT Trial Investigators (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367(24):2275–2283CrossRefPubMed Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W, MADIT-RIT Trial Investigators (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367(24):2275–2283CrossRefPubMed

Zurück zum Zitat Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, Alonso J, Nabutovsky Y, Neason C (2014) Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE Study. J Cardiovasc Electrophysiol 25(1):52–59CrossRefPubMed Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, Alonso J, Nabutovsky Y, Neason C (2014) Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE Study. J Cardiovasc Electrophysiol 25(1):52–59CrossRefPubMed

Zurück zum Zitat Healy B, Campeau L, Gray R, Herd JA, Hoogwerf B, Hunninghake D, Knatterud G, Stewart W, White C (1989) Conflict of interest guidelines for a multicenter clinical trial of treatment after coronary artery bypass-graft surgery. N Engl J Med 320(14):949–951CrossRefPubMed Healy B, Campeau L, Gray R, Herd JA, Hoogwerf B, Hunninghake D, Knatterud G, Stewart W, White C (1989) Conflict of interest guidelines for a multicenter clinical trial of treatment after coronary artery bypass-graft surgery. N Engl J Med 320(14):949–951CrossRefPubMed

Zurück zum Zitat Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices), American Association for Thoracic Surgery, Society of Thoracic Surgeons (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117(21):e350–e408CrossRefPubMed Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices), American Association for Thoracic Surgery, Society of Thoracic Surgeons (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117(21):e350–e408CrossRefPubMed

Zurück zum Zitat Hinkle LE Jr, Thaler HT (1982) Clinical classification of cardiac deaths. Circulation 65(3):457–464CrossRefPubMed Hinkle LE Jr, Thaler HT (1982) Clinical classification of cardiac deaths. Circulation 65(3):457–464CrossRefPubMed

Zurück zum Zitat Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883CrossRefPubMed Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883CrossRefPubMed

Zurück zum Zitat Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237CrossRefPubMed Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237CrossRefPubMed

Zurück zum Zitat Wilkoff BL, Hess M, Young J, Abraham WT (2004) Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 15(9):1002–1009CrossRefPubMed Wilkoff BL, Hess M, Young J, Abraham WT (2004) Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 15(9):1002–1009CrossRefPubMed

Zurück zum Zitat Lee IO, Ukena C, Böhm M, Buob A, Neuberger HR (2013) Underdetection of ventricular tachycardia by an implantable cardioverter-defibrillator due to a locally prolonged arrhythmia cycle length. Clin Res Cardiol 102(12):923–925CrossRefPubMed Lee IO, Ukena C, Böhm M, Buob A, Neuberger HR (2013) Underdetection of ventricular tachycardia by an implantable cardioverter-defibrillator due to a locally prolonged arrhythmia cycle length. Clin Res Cardiol 102(12):923–925CrossRefPubMed

Zurück zum Zitat Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M (2006) Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation 113(25):2871–2879CrossRefPubMed Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M (2006) Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation 113(25):2871–2879CrossRefPubMed

Zurück zum Zitat Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Blum Meisnere L, del Conyers M, Reynolds MR, Heidenreich PA, Al-Khatib SM, Pina IL, Blake K, Norine Walsh M, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J (2013) The National ICD Registry Report: Version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm 10(4):e59–e65CrossRefPubMed Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Blum Meisnere L, del Conyers M, Reynolds MR, Heidenreich PA, Al-Khatib SM, Pina IL, Blake K, Norine Walsh M, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J (2013) The National ICD Registry Report: Version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm 10(4):e59–e65CrossRefPubMed

Zurück zum Zitat Camm AJ, Nisam S (2010) European utilization of the implantable defibrillator: has 10 years changed the enigma? Europace 12(8):1063–1069CrossRef Camm AJ, Nisam S (2010) European utilization of the implantable defibrillator: has 10 years changed the enigma? Europace 12(8):1063–1069CrossRef

Zurück zum Zitat Markewitz A Jahresbericht des Deutschen Herzschrittmacher- und Defibrillatorregisters. Teil 2: Implantierbare Cardioverter-Defibrillatoren (ICD). https://www.pacemaker-register.de Markewitz A Jahresbericht des Deutschen Herzschrittmacher- und Defibrillatorregisters. Teil 2: Implantierbare Cardioverter-Defibrillatoren (ICD). https://​www.​pacemaker-register.​de

Zurück zum Zitat Wasmer K, Köbe J, Andresen D, Zahn R, Spitzer SG, Jehle J, Brachmann J, Stellbrink C, Martens E, Hochadel M, Senges J, Klein H, Eckardt L (2013) Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry. Clin Res Cardiol 102(7):513–521CrossRefPubMed Wasmer K, Köbe J, Andresen D, Zahn R, Spitzer SG, Jehle J, Brachmann J, Stellbrink C, Martens E, Hochadel M, Senges J, Klein H, Eckardt L (2013) Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry. Clin Res Cardiol 102(7):513–521CrossRefPubMed

Zurück zum Zitat van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ (2011) Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 57(5):556–562CrossRefPubMed van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ (2011) Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 57(5):556–562CrossRefPubMed